Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 40 results.
User Information
Export Records
  1. 1.   Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease
  2. Qiu, Yunguang; Hou, Yuan; Gohel, Dhruv; Zhou, Yadi; Xu, Jielin; Bykova, Marina; Yang, Yuxin; Leverenz, James B; Pieper, Andrew A; Nussinov,Ruth; Caldwell, Jessica Z K; Brown, J Mark; Cheng, Feixiong
  3. Cell Reports. 2024, Apr 21; 43(5): 114128.
  1. 2.   Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development
  2. Xu, Wenjing; Nelson-Maney, Nathan P; Bálint, László; Kwon, Hyouk-Bum; Davis, Reema B; Dy, Danielle C M; Dunleavey, James M; St Croix,Brad; Caron, Kathleen M
  3. International Journal of Molecular Sciences. 2022, May 20; 23(10):
  1. 3.   Kaposi sarcoma
  2. Cesarman, Ethel; Damania, Blossom; Krown, Susan E.; Martin, Jeffrey; Bower, Mark; Whitby,Denise
  3. NATURE REVIEWS DISEASE PRIMERS. 2019, Jan 31; 5(1):
  1. 4.   Proteolytically released Lasso/teneurin-2 induces axonal attraction by interacting with latrophilin-1 on axonal growth cones
  2. Vysokov, Nickolai V.; Silva, John-Paul; Lelianova, Vera G.; Suckling, Jason; Cassidy, John; Blackburn, Jennifer K.; Yankova, Natalia; Djamgoz, Mustafa B. A.; Kozlov,Serguei; Tonevitsky, Alexander G.; Ushkaryov, Yuri A.
  3. ELIFE. 2018, NOV 20; 7: pii: e37935..
  1. 5.   Regulation of inflammation by members of the formyl-peptide receptor family
  2. Chen, Keqiang; Bao, Zhiyao; Gong, Wang; Tang, Peng; Yoshimura, Teizo; Wang, Jiming
  3. JOURNAL OF AUTOIMMUNITY. 2017, DEC; 85: 64-77.
  1. 6.   Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
  2. Uldrick, T. S.; Whitby, D.
  3. Cancer Letters. 2011, Jun; 305(2): 150-162.
  1. 7.   Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties
  2. Yoshimura, T.; Oppenheim, J. J.
  3. Experimental Cell Research. 2011, Mar; 317(5): 674-684.
  1. 8.   Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta(2)-adrenergic receptor
  2. Shenoy, S. K.; Xiao, K. H.; Venkataramanan, V.; Snyder, P. M.; Freedman, N. J.; Weissman, A. M.
  3. Journal of Biological Chemistry. 2008 283(32): 22166-22176.
  1. 9.   Large-scale, saturating insertional mutagenesis of the mouse genome
  2. Gragerov, A.; Horie, K.; Pavlova, M.; Madisen, L.; Zeng, H.; Gragerova, G.; Rhode, A.; Dolka, I.; Roth, P.; Ebbert, A.; Moe, S.; Navas, C.; Finn, E.; Bergmann, J.; Vassilatis, D. K.; Pavlakis, G. N.; Gaitanaris, G. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Sep; 104(36): 14406-14411.
  1. 10.   Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity
  2. Brown, E. E.; Fallin, D.; Ruczinski, I.; Hutchinson, A.; Staats, B.; Vitale, F.; Lauria, C.; Serraino, D.; Rezza, G.; Mbisa, G.; Whitby, D.; Messina, A.; Goedert, J. J.; Chanock, S. J.; Kaposi Sarcoma Working, G.
  3. Cancer Epidemiology Biomarkers & Prevention. 2006, May; 15(5): 926-934.
  1. 11.   Host immunogenetics and control of human herpesvirus-8 infection
  2. Brown, E. E.; Fallin, M. D.; Goedert, J. J.; Hutchinson, A.; Vitale, F.; Lauria, C.; Giuliani, M.; Marshall, V.; Mbisa, G.; Serraino, D.; Messina, A.; Durum, S.; Whitby, D.; Chanock, S. J.; Kaposi Sarcoma Genetics Working Group
  3. Journal of Infectious Diseases. 2006, Apr; 193(8): 1054-1062.
  1. 12.   Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
  2. Zhang, N.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2005, DEC; 78(6): 1210-1214.
  1. 13.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 14.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 15.   Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis
  2. Le, Y. Y.; Ye, R. D.; Gong, W. H.; Li, J. X.; Iribarren, P.; Wang, J. M.
  3. Febs Journal. 2005, FEB; 272(3): 769-778.
  1. 16.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 17.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 18.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 19.   An expanding appreciation of the role chemokine receptors play in cancer progression
  2. Howard, O. M. Z.; Galligan, C. L.
  3. Current Pharmaceutical Design. 2004 10(19): 2377-2389.
  1. 20.   Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose
  2. Partida-Sanchez, S.; Iribarren, P.; Moreno-Garcia, M. E.; Gao, X. L.; Murphy, P. M.; Oppenheimer, N.; Wang, J. M.; Lund, F. E.
  3. Journal of Immunology. 2004 172(3): 1896-1906.
  1. 21.   A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay
  2. Glover, C. J.; Hite, K.; DeLosh, R.; Scudiero, D. A.; Fivash, M. J.; Smith, L. R.; Fisher, R. J.; Wu, J. W.; Shi, Y. G.; Kipp, R. A.; McLendon, G. L.; Sausville, E. A.; Shoemaker, R. H.
  3. Analytical Biochemistry. 2003 320(2): 157-169.
  1. 22.   Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphornas
  2. Kim, R.; Trubetskoy, A.; Suzuki, T.; Jenkins, N. A.; Copeland, N. G.; Lenz, J.
  3. Journal of Virology. 2003 77(3): 2056-2062.
  1. 23.   Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells
  2. Ptasznik, A.; Urbanowska, E.; Chinta, S.; Costa, M. A.; Katz, B. A.; Stanislaus, M. A.; Demir, G.; Linnekin, D.; Pan, Z. K.; Gewirtz, A. M.
  3. Journal of Experimental Medicine. 2002 196(5): 667-678.
  1. 24.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 25.   Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease
  2. Cui, Y. H.; Le, Y. Y.; Yazawa, H.; Gong, W. H.; Wang, J. M.
  3. Journal of Leukocyte Biology. 2002 72(4): 628-635.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel